Non-small-cell lung cancer (NSCLC) frequently harbors mutations in the epidermal growth factor receptor (EGFR), with exon 20 insertions comprising 1–10% of these mutations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.